INOMAX® Important Safety Information
INOMAX is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents.
Please see Full Prescribing Information.
Available to help you 24 hours a day, 7 days a week.
Let us know how we can help and we’ll quickly supply you with whatever information you need. Please do not use this form to report adverse events. Adverse event reporting should be directed to our Customer Care Department at 1-877-566-9466.
Mallinckrodt Pharmaceuticals does not share personal information provided by users of the INOMAX website with any third party.